Follow the people · Insider
Chirfi Guindo
Chirfi Guindo files insider transactions with the SEC as an evp, access, policy & comms of Merck & Co (MRK). We hold 5 disclosed purchases and sales filed since 5 December 2017, 2 of them in the last 90 days.
- Files forMRK
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure13 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 August 2022 — 13 August 2026EVP, Access, Policy & Comms · Merck & Co (MRK)30 Form 4 lines · source: SEC Form 4
- Filed 2 December 2024 — 3 June 2026Director · Beam Therapeutics (BEAM)3 Form 4 lines · source: SEC Form 4
- Filed 1 December 2017 — 18 February 2022Head of Glob Prod Strat & Com · Biogen (BIIB)49 Form 4 lines · source: SEC Form 4
Everything they disclosed
82 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 10,000 shares of Merck & CoSEC Form 413 August 2026Common Stock · traded 13 August 2026 · filed 13 August 2026
- ▼ sold on the open market 15,000 shares of Merck & CoSEC Form 47 August 2026Common Stock · traded 6 August 2026 · filed 7 August 2026
- was granted 19,676 shares of Beam Therapeutics (a derivative holding)SEC Form 45 June 2026Stock Option (Right to Buy) · traded 3 June 2026 · filed 5 June 2026
- was granted 6,628 shares of Merck & Co (a derivative holding)SEC Form 47 May 2026Restricted Stock Unit · traded 5 May 2026 · filed 7 May 2026
- was granted 19,402 shares of Merck & Co (a derivative holding)SEC Form 47 May 2026Stock Option (Right to Buy) · traded 5 May 2026 · filed 7 May 2026
- exercised options over 1,967 shares of Merck & CoSEC Form 41 May 2026Common Stock · traded 29 April 2026 · filed 1 May 2026
- had shares withheld for tax on 969 shares of Merck & CoSEC Form 41 May 2026Common Stock · traded 29 April 2026 · filed 1 May 2026
- exercised options over 1,967 shares of Merck & Co (a derivative holding)SEC Form 41 May 2026Restricted Stock Unit · traded 29 April 2026 · filed 1 May 2026
- ▼ sold on the open market 10,000 shares of Merck & CoSEC Form 412 February 2026Common Stock · traded 12 February 2026 · filed 12 February 2026
- ▼ sold on the open market 10,000 shares of Merck & CoSEC Form 412 February 2026Common Stock · traded 12 February 2026 · filed 12 February 2026
- ▼ sold on the open market 10,000 shares of Merck & CoSEC Form 49 February 2026Common Stock · traded 9 February 2026 · filed 9 February 2026
- ▼ sold on the open market 10,000 shares of Merck & CoSEC Form 49 February 2026Common Stock · traded 9 February 2026 · filed 9 February 2026
- ▼ sold on the open market 20,000 shares of Merck & CoSEC Form 46 February 2026Common Stock · traded 5 February 2026 · filed 6 February 2026
- ▼ sold on the open market 20,000 shares of Merck & CoSEC Form 46 February 2026Common Stock · traded 5 February 2026 · filed 6 February 2026
- was granted 9,865 shares of Merck & CoSEC Form 428 January 2026Common Stock · traded 26 January 2026 · filed 28 January 2026
- was granted 9,865 shares of Merck & CoSEC Form 428 January 2026Common Stock · traded 26 January 2026 · filed 28 January 2026
- exercised options over 36,903 shares of Merck & Co (a derivative holding)SEC Form 45 August 2025Restricted Stock Unit · traded 4 August 2025 · filed 5 August 2025
- exercised options over 36,903 shares of Merck & CoSEC Form 45 August 2025Common Stock · traded 4 August 2025 · filed 5 August 2025
- had shares withheld for tax on 18,175 shares of Merck & CoSEC Form 45 August 2025Common Stock · traded 4 August 2025 · filed 5 August 2025
- was granted 33,662 shares of Beam Therapeutics (a derivative holding)SEC Form 46 June 2025Stock Option (Right to Buy) · traded 4 June 2025 · filed 6 June 2025
- was granted 5,902 shares of Merck & Co (a derivative holding)SEC Form 41 May 2025Restricted Stock Unit · traded 29 April 2025 · filed 1 May 2025
- was granted 26,867 shares of Merck & Co (a derivative holding)SEC Form 41 May 2025Stock Option (Right to Buy) · traded 29 April 2025 · filed 1 May 2025
- was granted 28,158 shares of Merck & CoSEC Form 429 January 2025Common Stock · traded 27 January 2025 · filed 29 January 2025
- was granted 39,086 shares of Beam Therapeutics (a derivative holding)SEC Form 44 December 2024Stock Option (Right to Buy) · traded 2 December 2024 · filed 4 December 2024
- exercised options over 36,901 shares of Merck & Co (a derivative holding)SEC Form 46 August 2024Restricted Stock Unit · traded 5 August 2024 · filed 6 August 2024
- exercised options over 36,901 shares of Merck & CoSEC Form 46 August 2024Common Stock · traded 5 August 2024 · filed 6 August 2024
- had shares withheld for tax on 17,412 shares of Merck & CoSEC Form 46 August 2024Common Stock · traded 5 August 2024 · filed 6 August 2024
- was granted 29,297 shares of Merck & Co (a derivative holding)SEC Form 42 May 2024Stock Option (Right to Buy) · traded 30 April 2024 · filed 2 May 2024
- exercised options over 36,901 shares of Merck & Co (a derivative holding)SEC Form 44 August 2023Restricted Stock Unit · traded 3 August 2023 · filed 4 August 2023
- exercised options over 36,901 shares of Merck & CoSEC Form 44 August 2023Common Stock · traded 3 August 2023 · filed 4 August 2023
- had shares withheld for tax on 17,989 shares of Merck & CoSEC Form 44 August 2023Common Stock · traded 3 August 2023 · filed 4 August 2023
- was granted 34,578 shares of Merck & Co (a derivative holding)SEC Form 44 May 2023Stock Option (Right to Buy) · traded 2 May 2023 · filed 4 May 2023
- was granted 110,705 shares of Merck & Co (a derivative holding)SEC Form 44 August 2022Restricted Stock Unit · traded 3 August 2022 · filed 4 August 2022
- exercised options over 1,981 shares of Biogen (a derivative holding)SEC Form 423 February 2022Restricted Stock Unit · traded 18 February 2022 · filed 23 February 2022
- acquired or disposed of, other 2,851 shares of Biogen (a derivative holding)SEC Form 423 February 2022Restricted Stock Unit · traded 18 February 2022 · filed 23 February 2022
- exercised options over 1,981 shares of BiogenSEC Form 423 February 2022Common Stock · traded 18 February 2022 · filed 23 February 2022
- had shares withheld for tax on 879 shares of BiogenSEC Form 423 February 2022Common Stock · traded 18 February 2022 · filed 23 February 2022
- exercised options over 1,261 shares of Biogen (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 12 February 2022 · filed 15 February 2022
- acquired or disposed of, other 2,395 shares of Biogen (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 12 February 2022 · filed 15 February 2022
- exercised options over 1,336 shares of Biogen (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 12 February 2022 · filed 15 February 2022
- acquired or disposed of, other 2,480 shares of Biogen (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 12 February 2022 · filed 15 February 2022
- exercised options over 1,261 shares of BiogenSEC Form 415 February 2022Common Stock · traded 12 February 2022 · filed 15 February 2022
- had shares withheld for tax on 560 shares of BiogenSEC Form 415 February 2022Common Stock · traded 12 February 2022 · filed 15 February 2022
- exercised options over 1,336 shares of BiogenSEC Form 415 February 2022Common Stock · traded 12 February 2022 · filed 15 February 2022
- had shares withheld for tax on 593 shares of BiogenSEC Form 415 February 2022Common Stock · traded 12 February 2022 · filed 15 February 2022
- had shares withheld for tax on 1,189 shares of BiogenSEC Form 415 February 2022Common Stock · traded 12 February 2022 · filed 15 February 2022
- was granted 9,090 shares of Biogen (a derivative holding)SEC Form 414 February 2022Restricted Stock Unit · traded 10 February 2022 · filed 14 February 2022
- was granted 3,088 shares of BiogenSEC Form 421 January 2022Common Stock · traded 19 January 2022 · filed 21 January 2022
- ▼ sold on the open market 3,087 shares of BiogenSEC Form 49 June 2021Common Stock · traded 7 June 2021 · filed 9 June 2021
- was granted 14,500 shares of Biogen (a derivative holding)SEC Form 422 February 2021Restricted Stock Unit · traded 18 February 2021 · filed 22 February 2021
- exercised options over 1,534 shares of BiogenSEC Form 417 February 2021Common Stock · traded 12 February 2021 · filed 17 February 2021
- exercised options over 1,622 shares of BiogenSEC Form 417 February 2021Common Stock · traded 12 February 2021 · filed 17 February 2021
- had shares withheld for tax on 463 shares of BiogenSEC Form 417 February 2021Common Stock · traded 12 February 2021 · filed 17 February 2021
- had shares withheld for tax on 477 shares of BiogenSEC Form 417 February 2021Common Stock · traded 12 February 2021 · filed 17 February 2021
- exercised options over 1,534 shares of Biogen (a derivative holding)SEC Form 417 February 2021Restricted Stock Unit · traded 12 February 2021 · filed 17 February 2021
- acquired or disposed of, other 2,118 shares of Biogen (a derivative holding)SEC Form 417 February 2021Restricted Stock Unit · traded 12 February 2021 · filed 17 February 2021
- exercised options over 1,622 shares of Biogen (a derivative holding)SEC Form 417 February 2021Restricted Stock Unit · traded 12 February 2021 · filed 17 February 2021
- acquired or disposed of, other 2,194 shares of Biogen (a derivative holding)SEC Form 417 February 2021Restricted Stock Unit · traded 12 February 2021 · filed 17 February 2021
- exercised options over 481 shares of Biogen (a derivative holding)SEC Form 43 December 2020Restricted Stock Unit · traded 1 December 2020 · filed 3 December 2020
- acquired or disposed of, other 693 shares of Biogen (a derivative holding)SEC Form 43 December 2020Restricted Stock Unit · traded 1 December 2020 · filed 3 December 2020
- had shares withheld for tax on 348 shares of BiogenSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- exercised options over 481 shares of BiogenSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- had shares withheld for tax on 214 shares of BiogenSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- exercised options over 1,680 shares of Biogen (a derivative holding)SEC Form 414 February 2020Restricted Stock Unit · traded 12 February 2020 · filed 14 February 2020
- acquired or disposed of, other 1,972 shares of Biogen (a derivative holding)SEC Form 414 February 2020Restricted Stock Unit · traded 12 February 2020 · filed 14 February 2020
- was granted 11,450 shares of Biogen (a derivative holding)SEC Form 414 February 2020Restricted Stock Unit · traded 12 February 2020 · filed 14 February 2020
- exercised options over 1,680 shares of BiogenSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- had shares withheld for tax on 504 shares of BiogenSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- exercised options over 543 shares of Biogen (a derivative holding)SEC Form 43 December 2019Restricted Stock Unit · traded 1 December 2019 · filed 3 December 2019
- acquired or disposed of, other 625 shares of Biogen (a derivative holding)SEC Form 43 December 2019Restricted Stock Unit · traded 1 December 2019 · filed 3 December 2019
- had shares withheld for tax on 231 shares of BiogenSEC Form 43 December 2019Common Stock · traded 1 December 2019 · filed 3 December 2019
- exercised options over 543 shares of BiogenSEC Form 43 December 2019Common Stock · traded 1 December 2019 · filed 3 December 2019
- had shares withheld for tax on 160 shares of BiogenSEC Form 43 December 2019Common Stock · traded 1 December 2019 · filed 3 December 2019
- was granted 10,960 shares of Biogen (a derivative holding)SEC Form 414 February 2019Restricted Stock Unit · traded 12 February 2019 · filed 14 February 2019
- had shares withheld for tax on 231 shares of BiogenSEC Form 44 December 2018Common Stock · traded 1 December 2018 · filed 4 December 2018
- exercised options over 602 shares of BiogenSEC Form 44 December 2018Common Stock · traded 1 December 2018 · filed 4 December 2018
- had shares withheld for tax on 178 shares of BiogenSEC Form 44 December 2018Common Stock · traded 1 December 2018 · filed 4 December 2018
- exercised options over 602 shares of Biogen (a derivative holding)SEC Form 44 December 2018Restricted Stock Unit · traded 1 December 2018 · filed 4 December 2018
- acquired or disposed of, other 566 shares of Biogen (a derivative holding)SEC Form 44 December 2018Restricted Stock Unit · traded 1 December 2018 · filed 4 December 2018
- was granted 3,510 shares of Biogen (a derivative holding)SEC Form 48 January 2018Restricted Stock Unit · traded 1 December 2017 · filed 8 January 2018
- was granted 2,350 shares of BiogenSEC Form 45 December 2017Common Stock · traded 1 December 2017 · filed 5 December 2017
- was granted 1,755 shares of Biogen (a derivative holding)SEC Form 45 December 2017Restricted Stock Unit · traded 1 December 2017 · filed 5 December 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.